HOW DOES DOXORUBICIN INTERFERE WITH ACTIN POLYMERIZATION

被引：25

作者：

COLOMBO, R

MILZANI, A

机构：

来源：

关键词：

D O I：

10.1016/0167-4889(88)90038-9

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：9 / 16

页数：8

共 33 条

[1] ARENA E, 1975, ADRIAMYCIN REV, P160
[2] BENJAMIN RS, 1979, RECENT RESULT CANC R, V63, P230
[3] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4] ADRIAMYCIN - REVIEW
CARTER, SK
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (06) : 1265 - 1274
[5] DOXORUBICIN AFFECTS ACTIN ASSEMBLY INVITRO
COLOMBO, R
NECCO, A
VAILATI, G
SARACCO, B
MILZANI, A
SCARI, G
[J]. CELL BIOLOGY INTERNATIONAL REPORTS, 1984, 8 (02) : 127 - 135
[6] KINETIC EVIDENCE FOR A MONOMER ACTIVATION STEP IN ACTIN POLYMERIZATION
COOPER, JA
BUHLE, EL
WALKER, SB
TSONG, TY
POLLARD, TD
[J]. BIOCHEMISTRY, 1983, 22 (09) : 2193 - 2202
[7] PYRENE ACTIN - DOCUMENTATION OF THE VALIDITY OF A SENSITIVE ASSAY FOR ACTIN POLYMERIZATION
COOPER, JA
WALKER, SB
POLLARD, TD
[J]. JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 1983, 4 (02) : 253 - 262
[8] COOPER JA, 1982, METHOD ENZYMOL, V85, P182
[9] CORTES EP, 1975, CANCER CHEMOTH REP 3, V6, P215
[10] DOMAE N, 1981, CANCER TREAT REP, V65, P79